STAT+: In early glimpse at data, Akili’s video game shows positive results with adults with ADHD
Akili Interactive on Wednesday revealed earlier-than-expected top-line clinical trial results suggesting its video game treatment…
Category: STAT+
STAT+: Eli Lilly’s Alzheimer’s therapy slowed patients’ rate of cognitive decline, data show
A new treatment for Alzheimer’s disease developed by Eli Lilly slowed patients’ rate of cognitive…
STAT+: Biden’s pick to lead NIH stares down an increasingly political litany of questions
WASHINGTON — President Biden’s presumed pick to lead the National Institutes of Health, Monica Bertagnolli,…
.jpg)
STAT+: Disagreements and digs upend an otherwise bipartisan hearing on PBM reform
WASHINGTON — The first Senate health committee markup under Chairman Bernie Sanders (I-Vt.) and ranking…
STAT+: Pharmalittle: Senate PBM reform bill delays effective date; Gilead and HHS square off in court over HIV patents
Good morning, everyone, and how are you today? Steely skies are hovering this morning over…
STAT+: What to know about the upcoming readout of Eli Lilly’s experimental Alzheimer’s therapy
Eli Lilly is nearing the readout from a pivotal study of its experimental treatment for…
STAT+: Legal battle between Apple and Masimo over trade secrets ends in mistrial
A California jury was unable to reach a verdict in a messy, drawn-out legal battle…
STAT+: A battle between Gilead and the U.S. government over patents on HIV prevention pills goes to trial
After years of sparring, the federal government and Gilead Sciences will square off in a…
STAT+: Most of Canada’s public research universities get bad grades for ensuring access to drugs they discover
Despite significant public funding, most of the 15 largest public research universities in Canada failed…
STAT+: Senators delay start date for possible PBM reforms
WASHINGTON — Pharmacy benefit managers may have gotten themselves a slight reprieve. Senators drafting reforms to…
STAT+: Carbon Health blasts a major insurer in rare public dispute over coverage
OAKLAND, Calif. — Primary care startup Carbon Health blasted health insurer Elevance on Monday for…
STAT+: Pharmalittle: More biotechs are betting on obesity; Pfizer RSV vaccine faces hurdles in low-income countries
Good morning, everyone, and nice to see you again after a week-long respite in which…
STAT+: Astellas acquires Iveric Bio for $5.9B, entering competition to treat common cause of vision loss
Japanese drugmaker Astellas said late Sunday it would acquire eye drug developer Iveric Bio for…
STAT+: Sam Waksal and Jeremy Levin plot ‘the turnaround story of the century’
Over glasses of Chablis at Fleming by Le Bilboquet in Manhattan, two longtime friends and…
STAT+: Beyond Wegovy and Ozempic: Biotechs vie for piece of red-hot weight loss market with novel strategies
This is part of a series about new obesity drugs that are transforming patients’ lives,…
STAT+: New mega-deal highlights Geisinger’s fall, and raises concerns about where Kaiser is going next
In 2009, when President Barack Obama was touring the country and ginning up support for…
STAT+: Bright Health looks to get out of health insurance entirely
Bright Health Group started as a health insurance company. But it will no longer be…
STAT+: Once bullish on digital health, Orexo hits a wall on reimbursement
After several quarters of promising to deliver concrete progress on key digital therapeutics projects, Swedish…
STAT+: Pharmalittle: Amgen ends two lupus programs; Illumina sequencers have security vulnerability
Hello and happy Friday, with STAT reporter Andrew Joseph here steering the ship in place…
STAT+: Covid-19 burnished pharma’s reputation among patient groups, but access to medicines is now an issue
In the wake of the Covid-19 pandemic, the pharmaceutical industry enjoyed something of an afterglow,…
STAT+: FDA warns of security vulnerability in Illumina’s DNA sequencing machines
The Food and Drug Administration warned health care providers Thursday that a security vulnerability in…
STAT+: Pharmalittle: Lilly’s Mounjaro helped people lose 15.7% of body weight; Sanofi earnings boosted by Dupixent
Good morning everyone, from STAT reporter Andrew Joseph here filling in for Ed. Or, if…
STAT+: Eli Lilly’s Mounjaro succeeds in second weight-loss study, paving way for FDA review
The drug giant Eli Lilly said Thursday that its diabetes drug Mounjaro helped patients with…
STAT+: Six months after launch, Bert Vogelstein’s latest blood testing startup gets acquired for $450 million
Six months after launch, a startup founded by three leaders in the blood testing field…
STAT+: Pharma executives flood Bill Cassidy with campaign cash
WASHINGTON — Sen. Bill Cassidy’s new perch as the top Republican on the Senate health…
STAT+: Health insurance CEOs set another record for pay in 2022
Business has never been better for the largest health insurers in the country, which led…
STAT+: FDA approves Seres microbiome drug, as field advances
The Food and Drug Administration on Wednesday approved a new drug from Seres Therapeutics that…
STAT+: Facing headwinds, Teladoc tests its bet on whole-person care
Virtual care incumbent Teladoc beat Wall Street revenue estimates in the 2023’s first quarter —…
STAT+: Alnylam’s ‘upstream’ Alzheimer’s treatment shows early promise
An early-stage Alzheimer’s disease treatment from Alnylam Pharmaceuticals showed promising signs of benefit in a…
STAT+: Early findings in gene therapy death suggest CRISPR was not the cause
In February, four months after the first patient in a designer CRISPR therapy suddenly died,…
STAT+: Kaiser Permanente, Geisinger to merge into national health system
Kaiser Permanente and Geisinger have agreed to combine into a new national not-for-profit system that…
STAT+: Another powerful congressional committee is ready to take on PBMs
WASHINGTON — House Oversight Committee Chairman James Comer plans to hold a hearing on the…
STAT+: EU releases proposed pharma overhaul, cutting period of market exclusivity
LONDON — The European Commission on Wednesday unveiled a long-awaited proposed update for how the…
STAT+: Pharmalittle: EU unveils sweeping pharma reforms; new eye drug helps Roche beat the street
Hello, everyone. Damian Garde here, filling in for Ed Silverman once more as the working…
STAT+: RNA startup Orbital cinches $270 million investment
A new biotech founded by veterans of Alnylam Pharmaceuticals, Beam Therapeutics, ARCH Venture Partners, and…
Opinion: STAT+: At-home clinical trials are the future
In the early days of the Covid-19 pandemic, much of the clinical trials industry came…
STAT+: Medicare official insists drug price negotiation will consider value of drugs
WASHINGTON — When Medicare starts negotiating drug prices, it will take into account how important…
STAT+: FDA approves new treatment from Biogen for rare form of ALS
The Food and Drug Administration on Tuesday granted conditional approval to a new treatment for…
STAT+: Sens. Bernie Sanders, Bill Cassidy reach deal on PBM, generic reform
WASHINGTON — Senate health committee leaders Bernie Sanders and Bill Cassidy on Tuesday announced an agreement…
.jpg)
STAT+: Pharmalittle: Novartis boosts its sales and profit outlook; Biogen trims its drug pipeline
Good morning, one and all. Damian Garde here, filling in for Ed Silverman on an…
STAT+: Morphic study shows promise — and blockbuster potential — for a pill to treat ulcerative colitis
Morphic Therapeutic said Tuesday that an experimental oral medicine induced complete remissions in 26% of…
STAT+: Maryland pushes first-of-its-kind bill to promote alternatives to animals in biomedical research
Amid a push to use fewer animals in medical research, Maryland is on the verge…
STAT+: Pharmalittle: Weight-loss drug makers lobby Congress for Medicare coverage; Europe braces for new pharma legislation
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Bluebird submits sickle cell gene therapy to FDA for approval
Gene therapy developer Bluebio Bio said Monday that it has submitted a long-awaited application asking…
STAT+: How a small hospital in Nebraska has thrived through the pandemic
Great Plains Health is a small hospital system in a part of Nebraska surrounded by…
STAT+: ‘A tug of war’: Europe braces for new legislation with far-reaching impacts on pharma and patients
After more than two years of planning, the European Commission on Wednesday will release long-awaited…
STAT+: HCA bags big first quarter as patient volumes soar
Patient volumes are back in a big way, at least for the country’s largest for-profit…
STAT+: Pharmalittle: Lilly expects Medicare to back down on Alzheimer’s drug coverage; key senators change insulin cap proposal
And so, another working week will soon draw to a close. Not a moment too…
STAT+: FTC countersues HCA, Louisiana hospital system to stop acquisitions
The Federal Trade Commission on Thursday sued two hospital systems, HCA Healthcare and LCMC Health,…
STAT+: HCA, Louisiana hospital system sue FTC over review of hospital deal
HCA Healthcare and LCMC Health each sued the Federal Trade Commission and Department of Justice…